AMT
55
-3
KLAC
63
7
NDAQ
63
4
CL
56
-2
ISRG
71
5
NOV
48
3
NUE
54
4
BEN
48
2
APH
53
5
PNR
75
3
PSX
44
2
THC
64
3
CRM
59
9
MDLZ
67
-4
PEG
71
-3
ADBE
56
5
SE
68
3
PGR
65
-3
WEC
43
-3
LB
45
4
AMT
55
-3
KLAC
63
7
NDAQ
63
4
CL
56
-2
ISRG
71
5
NOV
48
3
NUE
54
4
BEN
48
2
APH
53
5
PNR
75
3
PSX
44
2
THC
64
3
CRM
59
9
MDLZ
67
-4
PEG
71
-3
ADBE
56
5
SE
68
3
PGR
65
-3
WEC
43
-3
LB
45
4
Financhill
Back

Futu Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
30

FUTU
Futu Holdings

Last Price:
65.57
Seasonality Move:
1.12%
Sell
28

ALNY
Alnylam Pharmaceuticals

Last Price:
273.83
Seasonality Move:
5.61%
Sell
30
Futu Holdings (FUTU) is a Sell

Is Futu Holdings a Buy, Sell or Hold?

  • The current Futu Holdings [FUTU] share price is $67.80. The Score for FUTU is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • FUTU is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $276.33. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FUTU Stock Price Chart

What is Futu Holdings's stock price today?

  • The Futu Holdings share price today is $67.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FUTU is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $276.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.

FUTU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 64.79 Buy
Chaikin Money Flow: 2738812 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.37 - 62.93) Buy
Bollinger Bands (100): (59.93 - 72.61) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.14 Buy
Relative Strength Index (14 RSI): 60.54 Buy
Chaikin Money Flow: -66637 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (256.89 - 278.47) Buy
Bollinger Bands (100): (164.63 - 269.71) Buy

FUTU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.73 Buy
20-day SMA: 60.41 Buy
50-day SMA: 61.1 Buy
200-day SMA: 59.67 Buy
8-day EMA: 61 Buy
20-day EMA: 60.45 Buy
50-day EMA: 61.65 Buy
200-day EMA: 60.66 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 267.42 Buy
20-day SMA: 266.35 Buy
50-day SMA: 259.79 Buy
200-day SMA: 191.66 Buy
8-day EMA: 269.14 Buy
20-day EMA: 265.86 Buy
50-day EMA: 253.52 Buy
200-day EMA: 208.02 Buy

Futu Holdings Earnings Growth & FUTU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.66 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.

Futu Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):